Postremission therapy with two different dose regimens of cytarabine in adults with acute myelogenous leukemia
- 31 December 1995
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 19 (12) , 893-897
- https://doi.org/10.1016/0145-2126(95)00082-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- Are we curing acute myelogenous leukemia?Leukemia Research, 1993
- Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemiaBlood, 1992
- Varying intensity of postremission therapy in acute myeloid leukemiaBlood, 1992
- The cytosine arabinoside (Ara‐C) syndromeMedical and Pediatric Oncology, 1981
- HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIAThe Lancet, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958